DOACs or VKAs or LMWH – What is the optimal regimen for cancer-associated venous thromboembolism? A systematic review and meta-analysis

BACKGROUND: Clinical guidelines have supported the use of direct anticoagulants (DOACs) for the treatment of cancer-associated venous thromboembolism (Ca-VTE). However, recent trials have reported increased bleeding risks associated with DOACs usage, raising concerns regarding its efficacy. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamani, Naser, Unzek, Samuel, Almas, Talal, Musheer, Adeena, Ejaz, Arooba, Paracha, Anousheh Awais, Shahid, Izza, Mookadam, Farouk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Systematic Review / Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289311/
https://www.ncbi.nlm.nih.gov/pubmed/35860059
http://dx.doi.org/10.1016/j.amsu.2022.103925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289311/
https://www.ncbi.nlm.nih.gov/pubmed/35860059
http://dx.doi.org/10.1016/j.amsu.2022.103925

Ejemplares similares